To understand whether the repression of NF-κB pathway could have a prognostic value for breast cancer patients, we performed survival analysis on TCGA database samples and confirmed a significant correlation between lower NF-κB and inflammatory response gene signature levels and a poorer prognosis of breast cancer patients (Fig. 4G and Supplementary Fig. 3H). This evidence concerns the gene NFKB1 and breast carcinoma.